• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射血分数保留和轻度降低的心力衰竭患者再住院和死亡率的预测模型:AD2NNER风险评分

Prediction model of rehospitalization and mortality in heart failure patients with preserved and mildly reduced ejection fraction: the AD2NNER risk score.

作者信息

Stoiculescu Flavia-Mihaela, Hădăreanu Diana-Ruxandra, Hădăreanu Călin-Dinu, Donoiu Ionuț, Istrătoaie Octavian, Raicea Victor-Cornel, Florescu Cristina

机构信息

Doctoral School, University of Medicine and Pharmacy of Craiova, Craiova, Romania.

Department of Cardiology, Clinical Emergency County Hospital of Craiova, Craiova, Romania.

出版信息

Front Cardiovasc Med. 2025 Jul 25;12:1605102. doi: 10.3389/fcvm.2025.1605102. eCollection 2025.

DOI:10.3389/fcvm.2025.1605102
PMID:40787235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12331685/
Abstract

AIMS

This study aimed to identify predictors of heart failure (HF) rehospitalization and explore their association with mortality in patients with preserved (HFpEF), and mildly reduced (HFmrEF) ejection fraction, leading to the development of a multivariable risk prediction score.

METHODS

We enrolled 1,022 HFpEF and HFmrEF inpatients discharged between January 2019 and May 2023. Demographic, clinical, biological, and imaging data were collected for analysis.

RESULTS

After a mean follow-up of 3.5 ± 1.4 years, 308 (30.1%) patients experienced HF rehospitalization. Univariable analysis revealed several parameters associated with HF rehospitalization, including age ( < 0.001), male sex ( = 0.015), type 2 diabetes mellitus (T2DM,  = 0.016), arterial hypertension ( = 0.018), smoking ( = 0.029), NYHA class at discharge ( = 0.006), atrial fibrillation ( = 0.003), ischemic or congenital etiology ( = 0.011), serum sodium ( = 0.002), and several echocardiographic measures. Multivariate Cox regression revealed six independent predictors: age (HR = 0.98,  < 0.001), T2DM (HR = 1.31,  = 0.026), NYHA class (HR = 1.39,  = 0.010), ischemic or congenital etiology (HR = 1.33,  = 0.037), atrial fibrillation (HR = 0.65,  = 0.001), and serum sodium level (HR = 0.97,  = 0.005). These formed the AD2NNER (age, T2DM, serum natrium, NYHA class, etiology, rhythm) score, ranging from 0 to 9 points. Kaplan-Meier analysis confirmed reduced event-free survival in patients with scores ≥4 (log-rank  = 0.005). Comparative Kaplan-Meier curves using an unweighted risk count (0-6) showed less distinct stratification. Subgroup analysis revealed robust score performance in HFpEF, but not HFmrEF alone. Higher AD2NNER scores were also associated with all-cause mortality.

CONCLUSION

The AD2NNER risk score is a simple, six-variable model that effectively predicts rehospitalization, and is also associated with mortality in patients with HFpEF and HFmrEF.

摘要

目的

本研究旨在确定射血分数保留(HFpEF)和轻度降低(HFmrEF)的心力衰竭(HF)患者再次住院的预测因素,并探讨这些因素与死亡率的关联,以开发一个多变量风险预测评分。

方法

我们纳入了2019年1月至2023年5月间出院的1022例HFpEF和HFmrEF住院患者。收集人口统计学、临床、生物学和影像学数据进行分析。

结果

平均随访3.5±1.4年后,308例(30.1%)患者再次住院。单变量分析显示了几个与HF再次住院相关的参数,包括年龄(<0.001)、男性(=0.015)、2型糖尿病(T2DM,=0.016)、动脉高血压(=0.018)、吸烟(=0.029)、出院时的纽约心脏协会(NYHA)分级(=0.006)、心房颤动(=0.003)、缺血性或先天性病因(=0.011)、血清钠(=0.002)以及一些超声心动图测量指标。多变量Cox回归显示了六个独立预测因素:年龄(HR=0.98,<0.001)、T2DM(HR=1.31,=0.026)、NYHA分级(HR=1.39,=0.010)、缺血性或先天性病因(HR=1.33,=0.037)、心房颤动(HR=0.65,=0.001)和血清钠水平(HR=0.97,=0.005)。这些因素构成了AD2NNER(年龄、T2DM、血清钠、NYHA分级、病因、心律)评分,范围为0至9分。Kaplan-Meier分析证实,评分≥4的患者无事件生存期缩短(对数秩检验=0.005)。使用未加权风险计数(0-6)的比较Kaplan-Meier曲线显示分层不太明显。亚组分析显示,该评分在HFpEF患者中表现稳健,但单独在HFmrEF患者中并非如此。较高的AD2NNER评分也与全因死亡率相关。

结论

AD2NNER风险评分是一个简单的六变量模型,能有效预测再次住院情况,并且与HFpEF和HFmrEF患者的死亡率也相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc76/12331685/c2cfb3efca06/fcvm-12-1605102-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc76/12331685/3aaf2c24179f/fcvm-12-1605102-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc76/12331685/7a7ca553b3a0/fcvm-12-1605102-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc76/12331685/64ae3215a9b3/fcvm-12-1605102-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc76/12331685/dd47636a135a/fcvm-12-1605102-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc76/12331685/c2cfb3efca06/fcvm-12-1605102-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc76/12331685/3aaf2c24179f/fcvm-12-1605102-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc76/12331685/7a7ca553b3a0/fcvm-12-1605102-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc76/12331685/64ae3215a9b3/fcvm-12-1605102-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc76/12331685/dd47636a135a/fcvm-12-1605102-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc76/12331685/c2cfb3efca06/fcvm-12-1605102-g005.jpg

相似文献

1
Prediction model of rehospitalization and mortality in heart failure patients with preserved and mildly reduced ejection fraction: the AD2NNER risk score.射血分数保留和轻度降低的心力衰竭患者再住院和死亡率的预测模型:AD2NNER风险评分
Front Cardiovasc Med. 2025 Jul 25;12:1605102. doi: 10.3389/fcvm.2025.1605102. eCollection 2025.
2
Sodium-glucose co-transporter 2 inhibitors in heart failure with mildly reduced or preserved ejection fraction: an updated systematic review and meta-analysis.钠-葡萄糖协同转运蛋白 2 抑制剂在射血分数轻度降低或保留的心衰中的应用:一项更新的系统评价和荟萃分析。
Eur J Med Res. 2022 Dec 29;27(1):314. doi: 10.1186/s40001-022-00945-z.
3
Optimal Pharmacologic Treatment of Heart Failure With Preserved and Mildly Reduced Ejection Fraction: A Meta-analysis.射血分数保留和轻度降低的心衰的最佳药物治疗:一项荟萃分析。
JAMA Netw Open. 2022 Sep 1;5(9):e2231963. doi: 10.1001/jamanetworkopen.2022.31963.
4
Association between insulin resistance indices and outcomes in patients with heart failure with preserved ejection fraction.射血分数保留的心力衰竭患者胰岛素抵抗指数与预后的关系
Cardiovasc Diabetol. 2025 Jan 22;24(1):32. doi: 10.1186/s12933-025-02595-x.
5
Atrial Fibrillation, Heart Failure Phenotypes, and Mortality Risk in the Nationwide START Registry: A Propensity Score Matching Analysis.全国START注册研究中的心房颤动、心力衰竭表型与死亡风险:一项倾向评分匹配分析
J Am Heart Assoc. 2025 Jun 17;14(12):e042586. doi: 10.1161/JAHA.125.042586. Epub 2025 Jun 16.
6
Etiology of Heart Failure Across the Ejection Fraction Spectrum and Association With Prognosis.射血分数范围内心力衰竭的病因及其与预后的关联
JACC Heart Fail. 2025 Aug;13(8):102491. doi: 10.1016/j.jchf.2025.03.037. Epub 2025 Jun 16.
7
Atrial Natriuretic Peptide at Discharge as a Predictive Marker for Early Rehospitalization in Patients With Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭患者出院时的心房利钠肽作为早期再住院的预测标志物
J Am Heart Assoc. 2025 Aug 19;14(16):e040320. doi: 10.1161/JAHA.124.040320. Epub 2025 Aug 12.
8
Outcomes of KDIGO-Defined CKD in U.S. Veterans With HFpEF, HFmrEF, and HFrEF.美国射血分数保留的心力衰竭(HFpEF)、射血分数中间值的心力衰竭(HFmrEF)和射血分数降低的心力衰竭(HFrEF)退伍军人中KDIGO定义的慢性肾脏病(CKD)的结局
JACC Heart Fail. 2025 Mar;13(3):467-479. doi: 10.1016/j.jchf.2024.11.007. Epub 2025 Feb 5.
9
Exercise-based rehabilitation for heart failure.基于运动的心力衰竭康复治疗
Cochrane Database Syst Rev. 2014 Apr 27;2014(4):CD003331. doi: 10.1002/14651858.CD003331.pub4.
10
Association between serum lactate and mortality in critically ill ischemic stroke patients based on MIMIC-IV data.基于MIMIC-IV数据的重症缺血性中风患者血清乳酸水平与死亡率之间的关联
Sci Rep. 2025 Jul 18;15(1):26155. doi: 10.1038/s41598-025-11461-5.

本文引用的文献

1
Machine learning in heart failure diagnosis, prediction, and prognosis: review.机器学习在心力衰竭诊断、预测及预后中的应用:综述
Ann Med Surg (Lond). 2024 May 6;86(6):3615-3623. doi: 10.1097/MS9.0000000000002138. eCollection 2024 Jun.
2
The WATCH-DM risk score estimates clinical outcomes in type 2 diabetic patients with heart failure with preserved ejection fraction.WATCH-DM 风险评分可预估射血分数保留型心力衰竭的 2 型糖尿病患者的临床结局。
Sci Rep. 2024 Jan 19;14(1):1746. doi: 10.1038/s41598-024-52101-8.
3
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.
4
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063. Epub 2022 Apr 1.
5
Global burden of heart failure: a comprehensive and updated review of epidemiology.心力衰竭的全球负担:流行病学的全面更新综述
Cardiovasc Res. 2023 Jan 18;118(17):3272-3287. doi: 10.1093/cvr/cvac013.
6
Similarities and Differences Between HFmrEF and HFpEF.射血分数保留的心力衰竭(HFpEF)与射血分数中间值的心力衰竭(HFmrEF)之间的异同
Front Cardiovasc Med. 2021 Sep 20;8:678614. doi: 10.3389/fcvm.2021.678614. eCollection 2021.
7
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
8
Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides.射血分数中等范围的心力衰竭:凡事皆有两面性。
Front Cardiovasc Med. 2021 Jul 21;8:683418. doi: 10.3389/fcvm.2021.683418. eCollection 2021.
9
Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes.糖尿病心力衰竭的流行病学、病理生理学、诊断和治疗。
Diabetes Metab J. 2021 Mar;45(2):146-157. doi: 10.4093/dmj.2020.0282. Epub 2021 Mar 25.
10
Risk factors for hospital readmission in older adults within 30 days of discharge - a comparative retrospective study.老年人出院后 30 天内再次住院的风险因素——一项比较性回顾性研究。
BMC Geriatr. 2020 Nov 11;20(1):467. doi: 10.1186/s12877-020-01867-3.